Last updated 2026-08-20
- Raised $24M Series A led by OurCrowd, Aug 2022
- Raised $5.5M Seed round, 2017
- Raised $400k grant led by NRC-IRAP, Apr 2020
Total raised
$30.9M
Stage
—
Founded
2017
Headcount
23
HQ
Vancouver, Canada
Sector
Biotechnology
Website ↗Registrar ID: 516614377 (SaNOtize Research and Development Corp.)
About
SaNOtize is a global pharmaceutical company that developed a disruptive, first-in-class technology to deliver the natural properties and advantages of nitric oxide (NO) for the first time. The company, based in Vancouver, Canada, is developing and commercializing products that deliver the natural properties of nitric oxide (NO) for use in health and wellness. SaNOtize was co-founded in 2017 by Chris Miller, PhD, and Gilly Regev, PhD. During the COVID-19 pandemic, SaNOtize developed its first product — a nitric oxide (NO)-based nasal spray. SaNOtize is also advancing a pipeline of topical products designed for a wide variety of important health and wellness intended uses harnessing the natural benefits of Nitric Oxide. These include cleansers and gel products. SaNOtize products are now available in more than 20 countries worldwide.
Funding history · 6 rounds · $30.9M total
6 events/rounds · $30.9M Total Funding: $30.5M in Private Equity
Aug 2022
Apr 2020
★ NRC-IRAP
Mar 2020
Feb 2019
May 2018
2017
Headcount over time
23 employees (2026-09) · 1 point
Offices
Vancouver, Canada · HQ / main office
Q&A
- What is SaNOtize Research and Development Corp.'s primary focus?
- SaNOtize Research and Development Corp. is a pharmaceutical company focused on commercializing products that utilize the antimicrobial properties of nitric oxide (NO) for health and wellness, particularly for upper respiratory and topical infections.
- When was SaNOtize Research and Development Corp. founded?
- SaNOtize Research and Development Corp. was founded in 2017.
- What is the total amount of funding SaNOtize Research and Development Corp. has raised to date?
- SaNOtize Research and Development Corp. has raised a total of $30,900,000 USD.
- When did SaNOtize Research and Development Corp. complete its Series B funding round and who were the lead investors?
- In August 2022, SaNOtize Research and Development Corp. completed a Series B funding round, raising $24,000,000 USD. The lead investors included OurCrowd and Horizons Ventures.
- Who are the co-founders of SaNOtize Research and Development Corp.?
- The co-founders of SaNOtize Research and Development Corp. are Gilly Regev, who serves as Chief Strategy and Innovation Officer, and Chris Miller, who is the Chief Science Officer.
- Who is the current CEO of SaNOtize Research and Development Corp.?
- Steven Basta was appointed CEO of SaNOtize Research and Development Corp. in September 2023.
- What is SaNOtize Research and Development Corp.'s core technology?
- SaNOtize Research and Development Corp.'s core technology is the Nitric Oxide Releasing Solution platform technology (NORS™), which is used to treat and prevent upper respiratory and topical infections.
- Where is SaNOtize Research and Development Corp. headquartered?
- SaNOtize Research and Development Corp. is headquartered in Vancouver, Canada.
Team · 6
Chris Miller
Founder · Chief Science Officer, Co-founder
Mikael Svensson
Chief Executive Officer
Gibb Clarke
Chief Financial Officer
Teri Meding
VP of Business Operations and Technology Innovation
Jose Casillas
VP of Product Development and Manufacturing
Craig Fraser
Chairman of the Board
Sectors & technology
Primary sector
Biotechnology
Technologies
Target customers
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | sanotize.com |
|---|
Identifiers & details
| Founded | 2017 |
|---|---|
| Employees (exact) | 23 |
Radar intelligence
Patents
| EPO | 14 |
|---|
Web history (Wayback)
| Domain | sanotize.com |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 516614377 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2022-05-18 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2025 |
| Active charges / liens | 0 |
| Registry events | 4 — people (1), annual_report (2), violation (1) |
| Registered address | הרכבת 58 תל אביב - יפו |
Recent registry events
| Date | Event |
|---|---|
| 2025-08-31 | עדכון בעלי תפקידים |
| 2025-11-09 | דו~ח שנתי-הוספת דירקטור |
| 2025-11-09 | עדכון הפרה |
| 2025-11-09 | דו~ח שנתי-הסרת דירקטור |